 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.4.4.1.8
- Cystathionine beta-lyase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-cystathionine + H2O = L-homocysteine + NH3 + pyruvate
|
 |
 |
 |
 |
 |
L-cystathionine
|
+
|
H(2)O
|
=
|
L-homocysteine
|
+
|
NH(3)
|
+
|
pyruvate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Pyridoxal 5'-phosphate
|
 |
 |
 |
 |
 |
Pyridoxal 5'-phosphate
Bound ligand (Het Group name =
BLP)
matches with 45.45% similarity
|
|
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
cytoplasm
|
1 term
|
 |
|
Biological process
|
cellular amino acid metabolic process
|
3 terms
|
 |
|
Biochemical function
|
catalytic activity
|
5 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Med Chem
50:755-764
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Inhibitors of bacterial cystathionine beta-lyase: leads for new antimicrobial agents and probes of enzyme structure and function.
|
|
L.J.Ejim,
J.E.Blanchard,
K.P.Koteva,
R.Sumerfield,
N.H.Elowe,
J.D.Chechetto,
E.D.Brown,
M.S.Junop,
G.D.Wright.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The biosynthesis of methionine is an attractive antibiotic target given its
importance in protein and DNA metabolism and its absence in mammals. We have
performed a high-throughput screen of the methionine biosynthesis enzyme
cystathionine beta-lyase (CBL) against a library of 50 000 small molecules and
have identified several compounds that inhibit CBL enzyme activity in vitro.
These hit molecules were of two classes: those that blocked CBL activity with
mixed steady-state inhibition and those that covalently interacted with the
enzyme at the active site pyridoxal phosphate cofactor with slow-binding
inhibition kinetics. We determined the crystal structure of one of the
slow-binding inhibitors in complex with CBL and used this structure as a guide
in the synthesis of a small, focused library of analogues, some of which had
improved enzyme inhibition properties. These studies provide the first lead
molecules for antimicrobial agents that target cystathionine beta-lyase in
methionine biosynthesis.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
P.H.Lodha,
A.F.Jaworski,
and
S.M.Aitken
(2010).
Characterization of site-directed mutants of residues R58, R59, D116, W340 and R372 in the active site of E. coli cystathionine beta-lyase.
|
| |
Protein Sci, 19,
383-391.
|
 |
|
|
|
|
 |
A.Farsi,
P.H.Lodha,
J.E.Skanes,
H.Los,
N.Kalidindi,
and
S.M.Aitken
(2009).
Interconversion of a pair of active-site residues in Escherichia coli cystathionine gamma-synthase, E. coli cystathionine beta-lyase, and Saccharomyces cerevisiae cystathionine gamma-lyase and development of tools for the investigation of their mechanisms and reaction specificity.
|
| |
Biochem Cell Biol, 87,
445-457.
|
 |
|
|
|
|
 |
P.H.Lodha,
H.Shadnia,
C.M.Woodhouse,
J.S.Wright,
and
S.M.Aitken
(2009).
Investigation of residues Lys112, Glu136, His138, Gly247, Tyr248, and Asp249 in the active site of yeast cystathionine beta-synthase.
|
| |
Biochem Cell Biol, 87,
531-540.
|
 |
|
|
|
|
 |
A.A.Miller,
G.L.Bundy,
J.E.Mott,
J.E.Skepner,
T.P.Boyle,
D.W.Harris,
A.E.Hromockyj,
K.R.Marotti,
G.E.Zurenko,
J.B.Munzner,
M.T.Sweeney,
G.F.Bammert,
J.C.Hamel,
C.W.Ford,
W.Z.Zhong,
D.R.Graber,
G.E.Martin,
F.Han,
L.A.Dolak,
E.P.Seest,
J.C.Ruble,
G.M.Kamilar,
J.R.Palmer,
L.S.Banitt,
A.R.Hurd,
and
M.R.Barbachyn
(2008).
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.
|
| |
Antimicrob Agents Chemother, 52,
2806-2812.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
|